| |
 |
| |
Government
approves continuation of Credit Linked Capital Subsidy Scheme |
The Cabinet
Committee on Economic Affairs (CCEA) gave its approval to extend
the period of validity of CLCSS during XI Plan period for the benefit
of Micro and Small Enterprises.
The Ministry
of Micro, Small & Medium Enterprises has been operating for
technology up gradation of Small Scale Industries under which 15%
capital subsidy on the Institutional Finance was provided in specified
sub-sectors/products for induction of well established and improved
technologies approved under the scheme. The validity of this scheme
was upto 31.03.2007 i.e. the end of X Five Year Plan.
|
|
|
|
|
| |
 |
| |
Positive Budget for healthcare,
hospitals and pharma companies. The weighted deduction of 125%
to R&D will add back significantly to profits. Excise duties
coming down from 16% to 8% for all pharmaceutical products is
very positive for all patients and consumers. Custom duties for
lifesaving drugs coming down, excise duties coming down to nil
for lifesaving drugs; for HIV AIDS products excise duties coming
down is a very strong message for the industry, for the consumers.
|
| |
|
India
to develop microbicides at earliest: Ramadoss |
|
| |
"Microbicides
are still in research process. We are expecting vaccines (to
prevent HIV/AIDS) to come out early but it will take some
more time. Experts say that microbicides will come early,"
Union Health Minister Anbumani Ramadoss said addressing at
the Microbicides 2008 Conference |
|
|
|
|
|
| |
| |
| |
| |
| |
|
| |
|
| |
|
 |
|
|
France
invites Indian pharma majors to invest in
bio-clusters
|
 |
France
has placed top priority for creation of bio-clusters capable of measuring
up on the international level and bringing together all participants
from research to bio-manufacturing, and invited the Indian pharma
majors to make use of it.
Read
More
|
|
|
|
|
|
 |
$10
bn Biogenerics Market up for Grabs
India
Emerging as Key Global Biopharma Player
|
Biotechnology
is one of the sunrise sectors of the Indian economy. The industry
includes firms that use cells and biological molecules for applications
in medicine (both veterinary and human medicine), agriculture and
environment management. The Indian biotech industry consists of five
distinct segments: biopharma, bioservices, bioagri, bioindustrial
and bioinformatics. There are more than 325 companies operating in
these segments, with nearly 40% of the companies operating in the
biopharma sector.
|
|
|
|
| New
patents reached a record 156,100 an increase by 4.7% - WIPO |
 |
According to the provisional
data from the World Intellectual Property Organization (WIPO),
under the WIPO Patent Cooperation Treaty, the number of applications
from India has come down to 686 in 2007 from 831 in the previous
year. China, Japan and South Koreas were the main driver
behind record patent growth in 2007 accounting for more than
a quarter of new registrations. U.S. is still in # 1 slot
but China, Japan and South Korea saw large increases.
|
|
|
|
|
| |
|
 |
India
a major hub for clinical studies |
Indian Clinical
trial market is estimated to grow to $ 2 billion and the numbers
of hospitals that are engaged in global and local clinical trials
are expected to grow to 14,000 by 2010.
Drug under
development for a disease undergoes extensive studies in animals
and humans to establish its safety and efficacy at a particular
dose, prior to being marketed. Clinical trials represent a bridge
from early stage drug development to commercialization. This
bridge cannot be bypassed and is long and expensive to cross.
|
|
|
| Perennial
dawn in the Pharma Industry of Bangladesh |
|
Pharmaceuticals
sector is one of the fastest growing sectors of the economy
of Bangladesh, which has the opportunity to grow further
under the provision of the TRIPS Agreement of WTO - with
an output worth US $ 344 million annually
In
Bangladesh Pharmaceutical sector is one of the most developed
hi-tech sector, which is contributing to the country's economy.
The country is boasting of a pharma industry output worth
US $ 344 million annually with direct export trade with as
many as 27 countries. After tobacco, pharmaceutical is the
second largest revenue generating industry in Bangladesh.
|
 |
|
Read
More |
| |
 |
| |
Pharma
Bangladesh 2008 |
| Conference
and Exhibition Management Services Ltd is organizing Pharma
Bangladesh 2008 from April 10, 2008 to April 13, 2008 in China
Friendship Conference Centre at Dhaka, Bangladesh, Asia.
The
leading International Exhibition on Pharmaceutical, Raw Materials,
Active Ingredients, Processing Machinery, Packaging Machinery,
Equipments and Related Services for the Pharma Sector, will
be Bangladesh's' biggest Pharmaceutical Machinery & Technology
Exhibition and a one-stop single platform to showcase the
latest progress made, latest technology achieved for the Pharmaceutical
Industry.
|
|
|
|
 |
FEEDBACK |
|
Contact:
enquiry@newmediacomm.biz
New
Media Communication Pvt. Ltd., B-302, Twin Arcade, Military Road,
Marol, Andheri (E), Mumbai 400 059 India. Tel: + 91 22 29250690.
Fax: + 91 22 2925 5279.
Website: www.newmediacomm.com |
|
|
|
|
|
|
